Dallah Healthcare Co.’s Q1 2024 net profit jumped 26% to SAR 119.30 million from SAR 94.7 million in Q1 2023.
| Item | Q1 2023 | Q1 2024 | Change |
|---|---|---|---|
| Revenues | 716.64 | 784.06 | 9.4 % |
| Gross Income | 266.79 | 293.36 | 10.0 % |
| Operating Income | 132.49 | 143.22 | 8.1 % |
| Net Income | 94.66 | 119.30 | 26.0 % |
| Average Shares | 97.68 | 97.68 | - |
| EPS (Riyals) | 0.97 | 1.22 | 26.0 % |
| Item | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Revenues | 806.01 | 784.06 | (2.7 %) |
| Gross Income | 295.94 | 293.36 | (0.9 %) |
| Operating Income | 126.50 | 143.22 | 13.2 % |
| Net Income | 113.65 | 119.30 | 5.0 % |
| Average Shares | 97.68 | 97.68 | - |
| EPS (Riyals) | 1.16 | 1.22 | 5.0 % |
On a sequential basis, the net earnings grew by 5% from SAR 113.65 million.
Shareholders’ equity, after minority interest, reached SAR 3.32 billion as of March 31, 2024, up from SAR 3.12 billion a year earlier.
Argaam Investment Company has updated the Privacy Policy of its services and digital platforms. Know more about our Privacy Policy here.
Argaam uses cookies to personalize content, to provide social media features and analyze traffic, that we might also share with third parties. You consent to our cookies if you use this website
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}